AACR CANCER POLICY MONITOR

                                                                                                              JUNE 2009

HAMBURG ASSUMES POSITION AS FDA COMMISSIONER

President Obama's nominee wins Senate approval

By unanimous voice vote on May 18, the U.S. Senate confirmed Dr. Margaret A. Hamburg to lead the US Food and Drug Administration (FDA). The vote came two months after President Obama nominated her for the position.

Hamburg is a former commissioner of health for New York City and has also served as the assistant director of the National Institute of Allergy and Infectious Disease of the National Institutes of Health.

According to the Associated Press, Hamburg told senators at her confirmation hearing that she will use her position to help restore public confidence in the FDA by putting science first and by running an open and accountable operation.

In the News:

• FDA Group To Help Agency Become More Transparent To Public (The Wall Street Journal, June 2, 2009)

Read More from the June Edition of the AACR Cancer Policy Monitor:

• Appropriators Question President's Plan to Double Funding for Cancer Research
• Tobacco Regulation Bill Set to Become Law 
• Senator Contemplates Extending NIH Timeline for Allocating Stimulus Funds
• Congress Preparing to Vote on Health Reform Legislation by August
• CDC Director Named

Top